Evidence map›Paper›PMID 33732989›Full record

ArticleKidney international reports2021

Spectrum of Kidney Involvement in Patients with Myelodysplastic Syndromes.

Nora Schwotzer, François Provot, Simon Ville, Laurent Daniel, Awena Le Fur, Sébastien Kissling, Noémie Jourde-Chiche, Alexandre Karras, Anne Moreau, Jean-François Augusto and 7 more

Open access · goldAbstract read
In one paragraph

Article in Kidney international reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 2 countries.

Nora SchwotzerTransplantation Center, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Switzerland.
François ProvotDepartment of Nephrology and Renal Transplantation, CHRU de Lille, Lille, France.
Simon VilleDepartment of Nephrology and Immunology, CHU de Nantes, Nantes, France.
Laurent DanielPathology Department, CHU La Timone, Marseille, France.
Awena Le FurDepartment of Nephrology, CH La Roche-sur-Yon, La Roche-sur-Yon, France.
Sébastien KisslingService of Nephrology and Hypertension, Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland.
Noémie Jourde-ChicheDepartment of Nephrology, Aix-Marseille Univ, C2VN, INSERM, INRAE, AP-HM CHU de la Conception, Marseille, France.
Alexandre KarrasDepartment of Nephrology, Hôpital Européen Georges Pompidou, Paris, France.
Anne MoreauPathology Department, CHU de Nantes, Nantes, France.
Jean-François AugustoDepartment of Nephrology, CHU d'Angers, Angers, France.
Viviane GnemmiPathology Department, CHRU de Lille, Lille, France.
Hélène PerrochiaPathology Department, CHU de Montpellier, Montpellier, France.
Stanislas BatailleInstitut Phocéen de Néphrologie, Clinique Bouchard, Marseille, France.
Moglie Le QuintrecDepartment of Nephrology, CHU de Montpellier, Montpellier, France.
Jean-Michel GoujonDepartment of Pathology, CHU de Poitiers, Poitiers, France.
Samuel RotmanService of Clinical Pathology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Switzerland.
Fadi FakhouriService of Nephrology and Hypertension, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.
University of Lausanne · CHCentre Hospitalier Universitaire de Lille · FRCentre Hospitalier Universitaire de Montpellier · FRCentre Hospitalier Universitaire de Nantes · FRCentre Hospitalier Universitaire d'Angers · FRCentre Hospitalier Universitaire de Poitiers · FRHôpital de la Timone · FRHôpital Européen · FRInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · FRRoche (France) · FRUniversity Hospital of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMyelodysplastic syndromes (MDS) are characterized by a high prevalence of associated autoimmune manifestations. Kidney involvement has been rarely reported in MDS patients. We report on the spectrum of kidney pathological findings in MDS patients.

methodsWe retrospectively identified MDS patients who had undergone a kidney biopsy between 2001 and 2019 in nine Swiss and French nephrology centres.

resultsNineteen patients (median age 74 years [63-83]) were included. At the time of kidney biopsy, eleven (58%) patients had extra-renal auto-immune manifestations and sixteen (84%) presented with acute kidney injury. Median serum creatinine at diagnosis was 2.8 mg/dL [0.6-8.3] and median urinary protein to creatinine ratio was 1.2 g/g [0.2-11]. Acute tubulo-interstitial nephritis (TIN) was present in seven (37%) patients. Immunofluorescence study in one patient with acute TIN disclosed intense IgG deposits along the tubular basement membrane and Bowman's capsule. Other kidney pathological features included ANCA-negative pauci-immune necrotizing and crescentic glomerulonephritis (n = 3), membranous nephropathy (n = 2), IgA nephropathy (n = 1), IgA vasculitis (n = 1), immunoglobulin-associated membrano-proliferative glomerulonephritis type I (n=1), crescentic C3 glomerulopathy (n = 1), fibrillary glomerulonephritis (n = 1) and minimal change disease (n = 1). Eleven (58%) patients received immunosuppressive treatments, among whom one developed a severe infectious complication. After a median follow-up of 7 month [1-96], nine (47%) patients had chronic kidney disease stage 3 (n = 6) or 4 (n = 3) and five (26%) progressed to end-stage kidney disease. Three patients died.

conclusionsMDS are associated to several autoimmune kidney manifestations, predominantly acute TIN. MDS are to be listed among the potential causes of autoimmune TIN.

Indexed as

acute tubulointerstitial nephritisautoimmunitymyelodysplastic syndromes

Identifiers

PMID33732989
PMCPMC7938072
OpenAlexW3120685497

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.